GET THE APP
COVID-19 and Disease-Modifying Therapies with Immunosuppressive E
+44-73-6204-9920
editorial@journalres.com
Submit Manuscript
Journal of Multiple Sclerosis
ISSN - 2376-0389
NLM - 101654564
Navbar
Journal Home
Editorial Board
Author Guidelines
Aim & Scope
Instruction For Authors
Author Guidelines
Peer Review Process
Publication Ethics & Malpractice Statement
Articles in process
Archive
Submit Manuscript
Journal Contact
Mini Article - (2023) Volume 10, Issue 8
View PDF
Download PDF
COVID-19 and Disease-Modifying Therapies with Immunosuppressive Effects Targeting CD20
Antonio Carrager
1
*
,
Michal Frost
1
,
2
and
Richie Jane
2
*
Correspondence:
Antonio Carrager, Blizard Institute, Barts and The London School of Medicine, 4 Newark Street, London, UK,
Email:
Author info »
Introduction